IL-7 enhances Ag-specific human T cell response by increasing expression of IL-2R α and γ chains

被引:20
作者
Chou, YK
Bourdette, DN
Barnes, D
Finn, TP
Murray, S
Unsicker, L
Robey, I
Whitham, RH
Buenafe, AC
Allegretta, M
Offner, H
Vandenbark, AA
机构
[1] Vet Affairs Med Ctr, Serv Neurol, Portland, OR 97201 USA
[2] Oregon Hlth Sci Univ, Dept Neurol, Portland, OR 97201 USA
[3] Connet Corp, Palo Alto, CA 94303 USA
[4] Oregon Hlth Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA
关键词
IL-7; IL-2R; human T cells; survival factor;
D O I
10.1016/S0165-5728(99)00002-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin-7 has demonstrated potent enhancing effects on the growth and differentiation of several immature cell types, including thymocytes, and on survival of resting and antigen activated T cells. In this study, we evaluated the effects of IL-7 on post-thymic antigen-specific T cells from human blood. IL-7 was found to enhance proliferation responses and IFN-gamma secretion of myelin or recall Ag-specific Th1 cells through the selective up-regulation of the IL-2R alpha and gamma but not beta chains in both an Ag-dependent and Ag-independent manner, but did not affect monocytes, B cells, or NK cells. These functions of IL-7 enhanced the detection of Th1 but not Th2 cell frequency by > 2.5 fold, and promoted selection of kg-specific Th1 cells by the limiting dilution method. Moreover, IL-7 pretreatment conferred increased resistance of CD4 + T cells to CD8 + cell lysis, These studies demonstrate that IL-7 promotes the growth and survival of circulating Ag-specific human Th1 cells through a mechanism that probably involves the gamma c common receptor for IL-2 family members that includes IL-7. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:101 / 111
页数:11
相关论文
共 44 条
[31]   CLONING OF THE GAMMA-CHAIN OF THE HUMAN IL-2 RECEPTOR [J].
TAKESHITA, T ;
ASAO, H ;
OHTANI, K ;
ISHII, N ;
KUMAKI, S ;
TANAKA, N ;
MUNAKATA, H ;
NAKAMURA, M ;
SUGAMURA, K .
SCIENCE, 1992, 257 (5068) :379-382
[32]  
TAMURA T, 1995, J IMMUNOL, V155, P4692
[33]   THE IL-2/IL-2 RECEPTOR SYSTEM - A CURRENT OVERVIEW [J].
TANIGUCHI, T ;
MINAMI, Y .
CELL, 1993, 73 (01) :5-8
[34]  
TASWELL C, 1981, J IMMUNOL, V126, P1614
[35]  
Ting CC, 1996, CANCER IMMUNOL IMMUN, V43, P283
[36]  
TUSHINSKI RJ, 1991, EXP HEMATOL, V19, P749
[37]   EPISODIC CHANGES IN T-CELL FREQUENCIES TO MYELIN BASIC-PROTEIN IN PATIENTS WITH MULTIPLE-SCLEROSIS [J].
VANDENBARK, AA ;
BOURDETTE, DN ;
WHITHAM, R ;
CHOU, YK ;
HASHIM, GA ;
OFFNER, H .
NEUROLOGY, 1993, 43 (11) :2416-2417
[38]   FRACTIONATION OF CENTRAL-NERVOUS-SYSTEM MYELIN PROTEINS BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
VANNOORT, JM ;
ELOUAGMIRI, M ;
BOON, J ;
VANSECHEL, AC .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1994, 653 (02) :155-161
[39]   The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance [J].
VanParijs, L ;
Ibraghimov, A ;
Abbas, AK .
IMMUNITY, 1996, 4 (03) :321-328
[40]   Interleukin-7 treatment promotes the differentiation pathway of T-cell-receptor-αβ cells selectively to the CD8+ cell lineage [J].
Varas, A ;
Vicente, A ;
Jiménez, E ;
Alonso, L ;
Moreno, J ;
Muñoz, JJ ;
Zapata, AG .
IMMUNOLOGY, 1997, 92 (04) :457-464